- Home
- TARS vs BK^K Comparison
TARS vs BK^K Comparison
Compare TARS & BK^K Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
Current Price
$81.80
Company Overview
Basic Information| Metric | TARS | BK^K |
|---|---|---|
| Founded | 2016 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.8B | N/A |
| IPO Year | 2020 | N/A |
Fundamental Metrics
Financial Performance| Metric | TARS | BK^K |
|---|---|---|
| Price | $81.80 | N/A |
| Analyst Decision | Strong Buy | |
| Analyst Count | 9 | 0 |
| Target Price | ★ $76.56 | N/A |
| AVG Volume (30 Days) | ★ 409.3K | N/A |
| Earning Date | 11-04-2025 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $366,100,000.00 | N/A |
| Revenue This Year | $147.24 | N/A |
| Revenue Next Year | $53.11 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 182.44 | N/A |
| 52 Week Low | $38.51 | N/A |
| 52 Week High | $85.25 | N/A |
Technical Indicators
Market Signals| Indicator | TARS | BK^K |
|---|---|---|
| Relative Strength Index (RSI) | 62.74 | N/A |
| Support Level | $78.10 | N/A |
| Resistance Level | $85.25 | N/A |
| Average True Range (ATR) | 3.08 | 0.00 |
| MACD | -0.28 | 0.00 |
| Stochastic Oscillator | 55.70 | 0.00 |
Price Performance
Historical Comparison TARS
BK^K
About TARS Tarsus Pharmaceuticals Inc.
Tarsus Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the development and commercialization of therapeutics, starting with eye care. The company is focused on the development and commercialization of first-in-class therapeutic candidates to provide treatment for ophthalmic conditions. The company's candidate XDEMVY is a novel investigational eye drop to treat blepharitis caused by the infestation of Demodex mites, referred to as Demodex blepharitis.